Skip to content

MB-CART2019.1 in refractory MS

Status
Not yet recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517601-82-00
Acronym
M-2024-424
Enrollment
25
Registered
2025-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory Multiple Sclerosis

Interventions

None listed

Sponsors

Miltenyi Biomedicine GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026